Myers, Robert W.
Merck & Co., Inc., Rahway, NJ, USA (United States)
3 papers on CoChatORCID 0000-0003-2599-1050
Most cited papers
- Verified
Systemic pan-AMPK activator MK-8722 improves glucose homeostasis but induces cardiac hypertrophy
Myers, R. W., Guan, H.-P., Ehrhart, J., Petrov, A., Prahalada, S., Tozzo, E., Yang, X., Kurtz, M. M., Trujillo, M., Gonzalez Trotter, D., et al. (2017) · Science
Metabolism, Diabetes, and CancerNatural Antidiabetic Agents Studies
Cited by 346
- Verified
Discovery of MK-8722: A systemic, direct pan-activator of amp-activated protein kinase
Feng, D., Biftu, T., Romero, F. A., Kekec, A., Dropinski, J., Kassick, A., Xu, S., Kurtz, M. M., Gollapudi, A., Shao, Q., et al. (2018) · ACS Medicinal Chemistry Letters
Metabolism, Diabetes, and CancerNatural Antidiabetic Agents Studies
Cited by 64
- Verified
Selective Class I HDAC Inhibitors Based on Aryl Ketone Zinc Binding Induce HIV-1 Protein for Clearance
Liu, J., Kelly, J., Yu, W., Clausen, D., Yu, Y., Kim, H., Duffy, J. L., Chung, C. C., Myers, R. W., Carroll, S., et al. (2020) · ACS Medicinal Chemistry Letters
Histone Deacetylase Inhibitors ResearchHIV Research and Treatment
Cited by 32
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free